Sugar water injection eases carpal tunnel pain in small study
NCT ID NCT07371221
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a single injection of 5% dextrose (sugar water) guided by ultrasound to separate the median nerve from surrounding tissues in 37 people with mild-to-moderate carpal tunnel syndrome. Participants were followed for 3 months to see if pain and hand function improved. The goal was to see if this simple procedure could be a safe and effective alternative to surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- 5% dextrose solution
- What this could lead to
- If it works, this could offer a simple, non-surgical option to reduce pain and improve hand function in people with carpal tunnel syndrome.
- What could go wrong
- This is a small, single-group study with no comparison group, so results may not be generalizable. The procedure is still experimental and long-term benefits are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
37 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Jun 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 65 years * Electrophysiologically confirmed mild to moderate CTS on electroneuromyography (ENMG) * Paresthesia or dysesthesia that worsens at night or with repetitive wrist movement * Presence of at least one of the following clinical findings: 1. Numbness in the median nerve distribution 2. Decreased hand strength or thenar muscle weakness 3. Positive Phalen's test and/or Tinel's sign * Pain intensity of ≥3 on the Visual Analog Scale (VAS) Exclusion Criteria: * Previous carpal tunnel surgery * Severe CTS on ENMG * Polyneuropathy * Pregnancy * Injections in the same area within the last 3 months * Peripheral nerve injury, thoracic outlet syndrome, cervical radiculopathy, brachial plexopathy * Traumatic hand injury in the last 2 years * Inflammatory rheumatological disease * Thyroid and autoimmune disease
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome (CTS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Nafiz Korez Sincan State Hospital
Ankara, Ankara, 06340, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Three shots, one wrist: which injection best eases carpal tunnel?
- Scalpel vs sound waves: two carpal tunnel surgeries go head to head
- Can carpal tunnel surgery restore more than hand function?
- Does nerve healing keep pace with hand recovery after carpal tunnel surgery?
- Retraining the brain to ease carpal tunnel pain: a new approach put to the test
- Can a Two-Session acupuncture treatment match ten sessions for carpal tunnel?